Standard Biotools (LAB) Cash & Equivalents Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 132.13 Bn | 129.26 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 111.43 Bn | 102.21 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 68.97 Bn | 67.52 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.64 Bn | 1.29 Bn | -22.13% |
| 6 | Dexcom | 28.91 Bn | 27.79 Bn | 750.30 Mn | 23.57% |
| 7 | GE HealthCare Technologies | 28.86 Bn | 26.58 Bn | 1.98 Bn | -7.71% |
| 8 | Smith & Nephew | 28.12 Bn | 27.54 Bn | - | -10.02% |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 117.27% |
| 10 | Standard Biotools | 302.22 Mn | -152.96 Mn | 11.31 Mn | 73.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.17% |
| Dec 31, 2025 | -28.41% |
| Sep 30, 2025 | -38.94% |
| Jun 30, 2025 | -41.49% |
| Mar 31, 2025 | -46.78% |
| Dec 31, 2024 | 221.56% |
| Sep 30, 2024 | 163.44% |
| Jun 30, 2024 | 89.45% |
| Mar 31, 2024 | 151.92% |
| Dec 31, 2023 | -36.23% |
| Sep 30, 2023 | 31.42% |
| Jun 30, 2023 | 89.84% |
| Mar 31, 2023 | 269.23% |
| Dec 31, 2022 | 179.38% |
| Sep 30, 2022 | 101.86% |
| Jun 30, 2022 | 7,319.00% |
| Mar 31, 2022 | -38.93% |
| Dec 31, 2021 | -57.62% |
| Sep 30, 2021 | -58.66% |
| Jun 30, 2021 | -97.69% |